Jubilant Pharmova
JUBLPHARMA · Pharma > Pharmaceuticals & Drugs · Chairman: Shyam S Bhartia · MD: Hari S Bhartia · Listing date: Oct. 24, 1994 · Employees: 6000 · Noida · http://www.jubilantpharmova.com

Stock Price vs Company Growth
1d
5.0%
1w
5.1%
1m
7.3%
3m
29.2%
6m
68.1%
1y
181.6%
5y
19.6%
10y
25.4%
all
10.3%

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

₹ 1,189 5.0%
926
1,309
Company Overview

Sales
6,920 Cr
Growth: 5.9%
Profit after Tax
197 Cr
Growth: 25.7%
Mid Cap
18,937 Cr
P/E: 31.8x
Industry P/E: 36.3x
Fundamentals

Sales (Cr) ₹ 6,920
Growth 5.9%
EBITDA 14.9%
P/S 2.7x
Dividend 1.2%
P/E 31.8x
Book Value ₹ 353
PEG Ratio 5.1x
ROE 3.6%
P/B 3.2x
Shareholding Pattern

Institutions
East Bridge Capital Master Fund Limited
4.52 %
East Bridge Capital Master Fund I Ltd
3.17 %
Government Pension Fund Global
2.65 %
Nippon Life India Trustee Ltd-A/C Nippon India Pharma Fund
1.07 %
Promoters
Spb Trustee Company Private Limited & Ss Trustee Company Private Limited (Jointly On Behalf Of Shyam Sunder Bhartia Family Trust)
20.52 %
Hsb Trustee Company Private Limited & Hs Trustee Company Private Limited (Jointly On Behalf Of Hari Shanker Bhartia Family Trust)
19.0 %
Miller Holdings Pte Ltd
3.28 %
Mav Management Advisors Llp
3.15 %
Nikita Resources Private Limited
2.2 %
Others
Rakesh Radheshyam Jhunjhunwala
3.14 %
Rakesh Radheshyam Jhunjhunwala
1.58 %
Rakesh Radheshyam Jhunjhunwala
1.57 %
Iepf
1.24 %
Increase    Decrease    No change
Company Profile Detailed

Jubilant Life Sciences is an integrated global pharmaceutical and life sciences company engaged in pharmaceuticals, life science ingredients, drug discovery solutions and India branded pharmaceuticals.Business segmentsPharmaceuticalsLife Science IngredientsDrug Discovery & Development SolutionsIndia Branded PharmaceuticalsAwards2012NDTV Profit Business Leadership Award 2012 for Corporate Social Responsibility.
Investors (141)
Followers (21)